There are no data from the use of lunsotogene parvec in pregnant women. Animal reproductive and developmental toxicity studies have not been conducted with lunsotogene parvec.
In the US general population, the estimated background risk of major birth defects and miscarriage in clinically recognized pregnancies is 2% to 4% and 15% to 20%, respectively.
There are no data on the presence of lunsotogene parvec in human milk, the effects on the breastfed infant, or the effects on milk production.
No animal studies have been performed to evaluate the effects of lunsotogene parvec on carcinogenicity, mutagenesis, or impairment of fertility.
Because clinical trials are conducted under widely varying conditions, adverse reaction rates observed in the clinical trials of a drug cannot be directly compared to rates in the clinical trials of another drug and may not reflect the rates observed in practice.
The safety data described in this section reflect exposure to lunsotogene parvec in one study (Study DB-OTO-001) which treated 24 patients with OTOF gene associated profound sensorineural hearing loss. A total of 10 patients received unilateral dosing, and a total of 14 patients received bilateral dosing of lunsotogene parvec at a nominal dose of 7.2 × 1012 vg per ear. The median duration of follow-up was 45 weeks (range 9 to 115 weeks).
Table 1 lists the most common adverse reactions that occurred in ≥5% patients in Study DB-OTO-001.
Table 1. Adverse Reactions Occurring in ≥5% of Patients in Study DB-OTO-001 (N=24):
| Adverse Reaction | Overall n (%) |
| Otitis Media | 9 (38) |
| Vomiting | 8 (33) |
| Nausea | 7 (29) |
| Dizziness | 5 (21) |
| Procedural Pain | 4 (17) |
| Gait Disturbance | 2 (8) |
| Nystagmus | 2 (8) |
Other clinically significant adverse reactions each occurring in 1 patient included transient balance disorder (4%), abnormal otoacoustic emissions (4%), and wound dehiscence (4%).
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.